Skip to main content

#151130

Anti-CD1c [M241] mAb

Cat. #151130

Anti-CD1c [M241] mAb

Cat. #: 151130

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD1c (Human Thymus Leukaemia antigen)

Class: Monoclonal

Application: IHC ; IP ; RIA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Walter Bodmer

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD1c [M241] mAb
  • Alternate name: CD1c Molecule; CD1C Antigen; C Polypeptide; CD1c Antigen; Differentiation Antigen CD1-Alpha-3; Cortical Thymocyte Antigen; CD1C; BDCA1; CD1A; CD1; R7
  • Research fields: Cancer;Cell biology;Immunology
  • Clone: M241
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 45 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; IP ; RIA
  • Description: M241 is useful for identification and elimination of some leukaemias.
  • Immunogen: MOLT 4 cell line
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: CD1c (Human Thymus Leukaemia antigen)
  • Molecular weight: 45 kDa
  • Target background: Cluster of Differentiation 1c (CD1c) is one of five human CD1 isoforms, a family of b2-microglobulin-associated transmembrane proteins that bind and present lipid antigens to T cells.

Applications

  • Application: IHC ; IP ; RIA

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c.
  • Wen et al. 2016. J Immunol. :. PMID: 27296666.
  • Small et al. 1989. Hum Immunol. 25(3):181-93. PMID: 2670851.
  • Characterization of B cells in severe combined immunodeficiency disease.
  • Merle-Beral et al. 1988. Eur J Haematol. 41(3):197-203. PMID: 3263283.
  • Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
  • Matsumoto et al. 1986. J Immunol. 137(9):2907-12. PMID: 2428878.
  • Fn analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.
  • Knowles et al. 1982. Eur J Immunol. 12(8):676-81. PMID: 6754387.
  • A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.